We are pleased to announce the CE approval on iRes™2, our fastest 2.0Khz excimer laser, empowering the smallest 350um laser micro-spot to execute iVis proprietary full automated, real-time controlled, no-touch, cTen® surgical procedure, maximizing surgical performance and avoiding intra-operative risks.
We are pleased to announce the CE approval on CIPTA®2, the unique cloud-based software conceived for interactive ray-tracing customized corneal surgical planning
We are pleased to announce the achievement of the CE mark on SafeCross®+ medical device on May 7th, 2021.
SafeCross®+ is a riboflavin ophthalmic solution, patented by iVis Technologies, granting high cross-linking efficiency in poor oxygen environment.
The 4D Suite™ is an integrated ensemble of hardware and software devices.
We are pleased to announce you that iVis 11th International Users’ meeting will be held in the form of a Webinar.
We are pleased to inform you that, on the 21st of February 2020, iVis Technologies received the CE Certification (awarded in compliance with the MDD 93/42/EEC European directive) for the commercialization of SafeCross™ medical device.
We are glad to announce you that iVis Technologies received the Innovation 4.0 second absolute award at the Fair of Automation & Testing in Turin
Advanced therapeutic applications planned remotely by Cipta proprietary planning software and using state-of-the-art iRes 1kHz Laser Platform for Corneal Refractive Surgery, Remote Controlled Laser treatments – high definition preoperative exams using Precisio2 Corneal Tomographer and pMetrics Pupillometer.
For one of its inventions, iVis was granted the European patent EP 1 649 843 which relates to a smart control of the surface power density of surgical laser systems which becomes more and more important in increasingly fast laser systems.
